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A challenge for the clinician and the pathologistRita A. Depprich a,*, Jo¨rg G. Handschel a, Claus U. Fritzemeier a,
Rainer Engers b, Norbert R. Ku¨bler aa Department of Cranio- and Maxillofacial Surgery, Heinrich-Heine-University Duesseldorf,
Moorenstrasse 5, 40225 Duesseldorf, Germany
b Department of Pathology, Heinrich-Heine-University Duesseldorf, Moorenstrasse 5,
40225 Duesseldorf, GermanyReceived 8 September 2005; accepted 11 September 2005Summary Verrucous carcinoma (VC) a low-grade variant of squamous cell carci-
noma (SCC) with specific clinical, morphologic and cytokinetic features is amongst
the rarest of all oral cancers. A hybrid VC is a non-verrucous SCC that arises synchro-
nously with the VC. We report a case of a monstrous exophytic tumor in the oral cav-
ity. Histologic examination revealed distinct discrepancy to clinical observation.
After review of the literature pathogenesis, histopathology and therapeutic options
are discussed. The differential diagnosis of VC remains difficult and requires clinical
and pathologic data confrontation. As the malignant behaviour of hybrid VC is con-
fined to the non-VC component, careful examination of these tumors is recom-
mended.c 2005 Elsevier Ltd. All rights reserved.
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DBackground
Verrucous carcinoma (VC) first described in 1948 by
Lauren V. Ackerman1 is a form of squamous cell
carcinoma with specific clinical, morphologic and
cytokinetic features.2 The term VC refers to those
exophytic mucosal or cutaneous squamous tumors
that are heaped above the epithelial surface with741-9409/$ - see front matter c 2005 Elsevier Ltd. All rights rese
oi:10.1016/j.ooe.2005.09.006
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epprich).a papillary micronodular surface3 and pushing mar-
gins. Most tumors involving the upper aerodigestive
tract are found in the oral cavity with the glottic
larynx being the most frequent nonoral site.4 VC
representing 2–12% of all oral cancers is mainly
found in elderly men and closely aligned with the
use of tobacco.5,6 Other irritants to the oral muco-
sa such as bethel nut chewing, poor dental hygiene
and Human Papilloma Virus (HPV) infection have
been implicated in the development of oral VC.3
To date histological evaluation remains a problem
as benign microscopic appearance is controversal
to the tumor’s destructive clinical behavior. Thisrved.
86 R.A. Depprich et al.report describes a monstrous exophytic tumor in
the oral cavity that emerged a hybrid VC.Case report
The patient was a 73-year-old female from Yugo-
slavia with a history of diabetes and hypertension,
but no history of alcohol or nicotin when she first
came to our department in January 2004 complain-
ing about a supposed 7 month existing swelling of
the upper lip.
Clinical examination revealed an exophytic
tumor extending all along the upper lip and a sec-
ond similar smaller tumor on the right lower lip.
In the oral cavity the tumor covered almost allFigure 1 Preoperative view: an exophytic tumor extending
lower lip. In the oral cavity the tumor covered almost all th
Figure 2 Preoperative X-ray (left): showing basal clouding
upper alveolar arcus. Axial CT scan showing tumor mass in tthe right palate and the right buccal mucosa and
had infiltrated the upper and the lower lip (Fig. 1).
X-ray of the paranasal sinus showed basal cloud-
ing of the right maxillary sinus and destruction of
the right upper alveolar arcus. Preoperative CT
scan showed the enormous extension of the tumor
with infiltration of the right hard palate and the
right cheek mucosa and destruction of the maxil-
lary anterior and lateral septum (Fig. 2). Additional
PET revealed the huge size of the tumor but
showed no suspicious lymph nodes.
Several biopsies from the oral cavity and upper
lip revealed a well differentiated verrucous tumor.
Surgical treatment consisted of the resection of
half of the right hard and soft palate, half of the
right lower lip and the total upper lip. Reconstruc-
tion was performed using a modification of theall along the upper lip and a smaller tumor on the right
e right palate and the right buccal mucosa.
of the right maxillary sinus and destruction of the right
he right palate (right).
Figure 3 Postoperative view after resection of half of the right hard and soft palate, half of the right lower lip and
the total upper lip. Facial reconstruction with a modification of the Esser flap, reconstruction of the upper lip with
intraoral mucosa, maxillary defect reconstruction with a split skin.
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intraoral mucosa and the defect resulting from par-
tial resection of the maxilla was covered with a
split skin graft and a temporary prosthesis (Fig. 3).
The histopathological examination revealed a
verrucous squamous tumor (8.3 cm in diameter)
(Fig. 4A–F) that only partly exhibited marked ker-
atosis (Fig. 4A). In some parts the tumor showed
additional endophytic growth (Fig. 4B and C) with
sharply demarked pushing borders (Fig. 4D) and a
moderate lymphoplasmocytic inflammatory host
reaction (Fig. 4D). In these parts of the tumor the
squamous epithelium lacked cytologic atypia
(Fig. 4D), but at a distinct site slight cytological
atypia became evident and the tumor exhibited
unambiguous invasion of the stroma (Fig. 4E and
F). Based on this the tumor was classified as a ver-
rucous leukoplakia with focal progression into a
highly differentiated SCC (pT1, pNX, pMX, G1,
R0). After presentation of the clinical findings to
the pathologist the final histological diagnosis of a
hybrid VC arising from a proliferative verrucous
leukoplakia was made.
In December 2004 a tissue sample from a 3 mm
suspicious exophytic area of right lower lip pre-
sented recurrence of the high differentiated verru-
cous squamous cell carcinoma.
The planned surgical therapy could not be per-
formed as the patient had a crippling apoplectic
stroke and broke up coming to our department.Discussion
VC first described in 1948 by Lauren V. Ackerman is
a distinct variant of differentiated SCC with lowgrade malignancy, slow growth and no or only low
metastatic potential.2,7,8 It is often associated with
long-term use of smokeless tobacco although
examples occur among nonusers.6,9 Bethel nut
chewing, poor dental hygiene and Human Papil-
loma Virus (HPV) infection have been implicated
in the development of oral VC.3 The tumor repre-
senting 2–12% of all oral cancers mainly occurs in
older men (Koch et al. detected median age at
diagnosis 69.0 years,3 although many cases have
also been documented in older woman in areas
where the habit of snuff dipping has been popular
among women (e.g. West Virgina).5,6 Verucous car-
cinoma in association with lichen planus have been
reported.10,11
With respect to the upper aerodigestive tract,
where the VC most often arises, the oral cavity,
particularly the cheek mucosa, gingivae and retro-
molar areas, remains the most common site of ori-
gin.12 The tumor may also be found on different
sites including skin,13 paranasal sinus,14 bladder
and anorectal region,15 male and female
genitalia,16,17 sole of the foot,3 and ear.18
Macroscopically the VC shows up an exophytic,
broadly implanted tumor fungating in aspect with
a warty or papillary surface. The histological
appearance is described as highly differentiated
squamous tumor covered by a thick keratinized
layer arranged in deeply invaginated folds with a
typically inflammatory reaction in the stroma com-
posed of lymphocytes, plasma cells and histiocytes
that tend to delimit the tumor mass.19,20 The
sharply circumscribed deep margin is often charac-
terized as ‘‘pushing border’’.21 The benign micro-
scopic appearance is controversal to the tumor‘s
destructive clinical behavior, although lymph node
Figure 4 Histological characteristics. (A) Verrucous tumor showing a predominantly exophytic papillary growth
pattern with only little keratinisation and a mild inflammatory host reaction. (B) Other parts of the verrucous tumor
exhibiting exo- and endo-phytic growth characteristics with marked keratinisation (C), pushing borders (D), a dense
lymphoplasmocytic inflammatory host response (D) and a lack of cytological atypia (D). (E) Classical highly
differentiated squamous cell carcinoma with unambiguous invasion of the adjacent stroma and slight cytological
atypia (F).
88 R.A. Depprich et al.metastasis is not characteristic. The microscopic
aspect ranges from benign squamous hyperplastic
lesion to SCC.4
The etiology of VC remains unclear. The role of
Human papillomavirus (HPV) infections in the etiol-
ogy of verrucous lesion of the skin and genitalia is
well documented, and HPV may also play an impor-
tant role in the development of VC.22,23 The results
of a meta-analysis of 94 reports indicate that HPV is
2–3 times more likely to be detected in precancer-
ous oral mucosa and 4.7 times more likely to be de-
tected in oral SCC. The likelihood of detecting HPV
in VC was found to be 29.5% and 46.5% in oral SCC.24
The development of VC from proliferative le-
sions makes it likely that the tumor develops froma benign precursor.25 Thus, Hansen et al. described
10 histologic stages of proliferative verrucous leu-
koplakia,26 ranging from a persistant and slow-
growing benign unifocal, homogenous leukoplakia
to a less differentiated squamous cell carcinoma.
Batsakis et al. reduced the number of histologic
stages to the following four: clinical flat leukopla-
kia without dysplasia, verrucous hyperplasia, VC,
and conventional SCC.27
The histologic similarity between verrucous
hyperplasia and VC is so close that some authors
consider verrucous hyperplasia as a morphologic
variant of VC.28 Batsakis et al. regard verrucous
hyperplasia as an irreversible precursor of VC and
recommend the same treatment.27
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ferentiated SCC were found in proliferative activity
of tumor cells as evaluated by PCNA labeling index
or in p53 protein expression. However positive
expression of CD44v9 was detected clearly more
often in VC compared to well-differentiated squa-
mous cell carcinoma, which might provide an
explanation for the low incidence of lymph node
metastasis in oral VC.29
Difficulties remain as to the appropriate classifi-
cation of those lesions with dominant features of
VC which also contain small foci of squamous cell
carcinoma. In 20% of VC coexistent foci of less-dif-
ferentiated SCC could be found.21 A non-verrucous
SCC (of varying degree and differentiation) that
arises synchronously with the VC and in the same
microscopic fields is defined by Batsakis et al. as
a ‘‘hybrid VC’’,4 which must be separated from
papillary squamous carcinoma.20,23,30
Wide surgical excision is recommended as treat-
ment of choice, since some studies suggested that
anaplastic transformation of the tumor can occur
after radiotherapy.3,4,31 However other authors re-
ported that the response of VC to radiotherapy is
comparable to that of SCC.32–35 Batsakis et al.
believe that the hybrid carcinoma may be the car-
cinoma responsible for the phenomena of post-
radiation ‘anaplastic transformation’. They
hypothesize the biologic course of such a hybrid
malignancy to be that of the non-VC.27
Operative treatment of VC should not include
neck dissection, even though enlarged lymph nodes
may be palpated.19
Recently successfull treatment of an extensive
VC with intra-arterial infusion of methotrexate36
or topical 5-aminolevulinic acid-mediated photody-
namic therapy was reported.37
No matter what the treatment is, the rate of
local recurrences is said to be high ranging from
30% to 50%7,31,33,38 and not unusually is the result
of inadequate surgery because of the size of the
tumor and left dysplasia close to the verrucous
carcinoma.7,39
In our case the patient offered typically clinical
features of a VC: a monstrous fungating tumor of
the oral cavity with local destruction of the adja-
cent anatomical structures but no hint of lymph
node mestastasis. Also in our case the histological
classification of the verrucous tumor was difficult
as the histologial appearance of different verrucous
lesions is overlapping. Therefore, after presenting
the clinical findings as well as the anamnestic infor-
mations of initially multifocal lesions in the absence
of tobacco consumption to the pathologist, the final
diagnosis of a hybrid VC, arising from a proliferative
verrucous leukoplakia, was made. We hypothesizethat the local recurrence after almost one year
gives evidence of the premalignant potential of
the mucosa as VC is very often linked with such pre-
malignant alterations of the mucous membrane.Conclusion
The differential diagnosis of VC remains difficult
and requires clinical and pathological data confron-
tation. As the malignant behaviour of hybrid VC is
confined to the non-VC component, careful exami-
nation of these tumors is recommended.References
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